Patient Support Services
Eliminating financial barriers to patient treatment
Our experience in providing patient affordability programs spans over 23 years.
Life Sciences Partners
With an ISO 27001 certification, Mercalis guarantees the gold standard in protected health information security management.
Patient Access and Affordability
Solutions for access and affordability are fully integrated into our patient support services programs. This integration helps align the financial assistance needs of the patient with the strategic business expectations of life science brands.
Free Goods Pharmacy
Our non-commercial pharmacy can dispense consigned products, providing free goods to patients in need. By supporting QuickStart and Bridge programs, we can also help engineer a successful start to therapy by directing the transmission of electronic prescriptions from EMR systems to pharmacies.
Nursing Support Services
Mercalis offers multiple channels to improve clinical education and patient support, including nurse support and digital patient support. We help create multi-faceted programs with onsite, in-house nurse educators to provide product and disease education, combined with adherence, resources, and psychosocial support.
Patient Engagement and Adherence
Our end-to-end digital platform delivers hassle-free patient support for specialty drug programs and clinical trials, such as text message alerts for copay enrollment and ongoing adherence reminders, improving adherence and helping build long-term relationships.
Mercalis serves as a centralized contract to acquire eServices for patient support programs. After selecting what solutions are needed in your eServices strategy, program operations is free to focus on what really matters—simplifying access to therapy for your patients.
Clinical Trial Support
Our RxStudy Card™ product meets the needs of any phase study that mandates approved medication and supplies be dispensed through retail and specialty pharmacies. The first of its kind, RxStudy Card™ is utilized by over half of the top 25 biotech/pharmaceutical companies and seven of the top ten CROs in the United States.